Treatment of Elevated Homocysteine: A Potential Risk Factor for Vascular Disease

E-ISSN： 1875-6107|5|2|125-139

ISSN： 1568-0134

Source： Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol.5, Iss.2, 2005-04, pp. : 125-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Total homocysteine as a risk factor for vascular disease in renal transplant recipients

By Juskowa J. Bartlomiejczyk J. Paczek L. Rowinski W. Szmidt J. Foroncewicz B. Mucha K. Plominski Y.P.

Transplantation Proceedings, Vol. 34, Iss. 2, 2002-03 ,pp. : 576-579

Elsevier

Access to resources Recommend Favorite

Elevated Factor VIII as a Marker for Vascular Type of Rejection After Renal Transplantation

By van Son W.J. Brijker F. Elema J.D. Tegzess A.M. van der Meer J.

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 161-163

Elsevier

Access to resources Recommend Favorite

Genetic variants of homocysteine metabolizing enzymes and the risk of coronary artery disease

By Janosikova B. Pavlikova M. Kocmanova D. Vitova A. Vesela K. Krupkova L. Kahleova R. Krijt J. Kraml P. Hyanek J. Zvarova J. Andel M. Kozich V.

Molecular Genetics and Metabolism, Vol. 79, Iss. 3, 2003-07 ,pp. : 167-175

Elsevier

Access to resources Recommend Favorite

Betaine-Homocysteine Methyltransferase (BHMT): Genomic Sequencing and Relevance to Hyperhomocysteinemia and Vascular Disease in Humans

By Heil S.G. Lievers K.J.A. Boers G.H. Verhoef P. den Heijer M. Trijbels F.J.M. Blom H.J.

Molecular Genetics and Metabolism, Vol. 71, Iss. 3, 2000-11 ,pp. : 511-519

Academic Press

Access to resources Recommend Favorite

Targeting the Vascular Endothelial Growth Factor Pathway in the Treatment of Human Malignancy

By Tonra James Hicklin Daniel

Immunological Investigations, Vol. 36, Iss. 1, 2007-01 ,pp. : 3-23

Informa Healthcare

Access to resources Recommend Favorite